Clara BioTech QuadChart
Abstract
Clara Biotech's platform enables a number of technologies in the exciting field of exosomes. Our device is currently a single-use consumable and a tool the size of a shoe box, allowing it to be placed in any lab setting. Ongoing BETA evaluation with paying customers (academic, diagnostics, drug development). Breakthrough exosome technology that enables new ways to diagnose and treat diseases and exposures such as cancer, infection and brain injury.
Document Details
- Document Type
- Technical Report
- Publication Date
- Sep 13, 2021
- Accession Number
- AD1151121
Entities
People
- Jim West
Organizations
- United States Central Command